2m 2m 2m 2m 2m 2m 2m
GOSSAMER BIO (GOSS)
NASDAQ
$0.19-$0.01 (-7.09%)
Price as of Jun 03, 2026 7:13 PM EDT- $54.2MMarket Cap
- -83.59%1-Year Change
- BiotechnologyIndustry
GOSSAMER BIO (GOSS)
$0.19-$0.01 (-7.09%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 0 -100.00% | 114.7M N/A | N/A N/A | 0 N/A | |
Cost of Revenue | 173.6M +34.34% | 129.2M N/A | N/A N/A | N/A N/A | |
Gross Profit | -173.6M +1,093.70% | -14.5M N/A | 0 N/A | 0 N/A | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -174.1M +25.71% | -138.5M +2.35% | -135.3M -20.87% | -171.0M +0.38% | |
Depreciation and Amortization Expense | 24,000 -97.12% | 833,000 -48.16% | 1.6M -12.28% | 1.8M +5.29% | |
Total Operating Expenses | 219.2M +25.53% | 174.6M -4.97% | 183.8M -15.94% | 218.6M +1.14% | |
Operating Profit | -170.7M +184.93% | -59.9M -67.39% | -183.8M -15.94% | -218.6M +1.14% | |
Interest Income | 2.0M +10.74% | 1.8M -10.92% | 2.0M +26.15% | 1.6M +108.02% | |
Interest Expense | -11.0M +0.48% | -10.9M -19.09% | -13.5M -2.66% | -13.9M -28.60% | |
Interest Income and Expense and Net | -9.0M -1.51% | -9.2M -20.51% | -11.5M -6.37% | -12.3M -34.17% | |
Total Nonoperating Income and Expense | 270,000 -93.70% | 4.3M +8.68% | 3.9M +160.71% | 1.5M +89.24% | |
Income before Taxes | -170.5M +206.39% | -55.6M -69.72% | -183.8M -15.94% | -218.6M +1.14% | |
Income Taxes | -88,000 -109.85% | 893,000 N/A | N/A N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -170.4M +201.39% | -56.5M -68.56% | -179.8M -21.61% | -229.4M -1.98% | |
Net Income from Continuing Operations Applicable to Common | -170.5M +206.39% | -55.6M -69.06% | -179.8M -21.61% | -229.4M -1.98% | |
Basic EPS and Net Income | -0.75 +200.00% | -0.25 -78.81% | -1.18 -56.46% | -2.71 -13.42% | |
Diluted EPS and Net Income | -0.75 +200.00% | -0.25 -78.81% | -1.18 -56.46% | -2.71 -13.42% | |
Basic Weighted Average Shares | 228.5M +1.01% | 226.2M +48.23% | 152.6M +80.46% | 84.6M +13.00% | |
Diluted Weighted Average Shares | 228.5M +1.01% | 226.2M +48.23% | 152.6M +80.46% | 84.6M +13.00% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 37.7M -18.11% | 46.1M +43.49% | 32.1M -71.32% | 112.0M -38.95% | |
Short-Term Investments | 99.2M -60.07% | 248.4M -6.00% | 264.3M +83.93% | 143.7M +1.33% | |
Cash and Cash Equivalents and Short-Term Investments | 136.9M -53.51% | 294.5M -0.64% | 296.4M +15.94% | 255.7M -21.38% | |
Total Current Assets | 167.6M -45.90% | 309.9M +1.10% | 306.5M +17.05% | 261.9M -21.07% | |
Accumulated Depreciation | 207,000 +13.11% | 183,000 -96.63% | 5.4M -11.13% | 6.1M +42.80% | |
Property and Plant and Equipment and Net | 64,000 +540.00% | 10,000 -99.39% | 1.6M -58.60% | 4.0M -25.17% | |
Total Long-Term Assets | 408,000 +44.17% | 283,000 -54.21% | 618,000 -9.12% | 680,000 -37.04% | |
Total Assets | 172.2M -45.37% | 315.3M +1.08% | 311.9M +14.49% | 272.4M -20.72% | |
Income Taxes Payable | 6,000 N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 0 N/A | 0 -100.00% | 11.6M 0.00% | 11.6M N/A | |
Total Current Liabilities | 63.4M +40.94% | 45.0M -12.77% | 51.6M +4.81% | 49.2M +23.51% | |
Total Long-Term Debt | 198.5M N/A | 0 -100.00% | 814,000 -93.21% | 12.0M -58.77% | |
Total Long-Term Liabilities | 33.1M -23.58% | 43.3M +4,416.39% | 958,000 -93.79% | 15.4M -52.21% | |
Total Liabilities | 295.0M +3.22% | 285.8M +14.71% | 249.1M -4.31% | 260.4M +17.18% | |
Retained Earnings | -1.4B +13.43% | -1.3B +4.66% | -1.2B +17.42% | -1.0B +27.19% | |
Total Stockholders Equity | -122.8M -516.25% | 29.5M -53.02% | 62.8M +419.74% | 12.1M -90.06% | |
Total Shares Outstanding | 233.7M +3.12% | 226.6M +0.53% | 225.4M +138.72% | 94.4M +24.65% | |
Cash Flow | |||||
Cash from Operating Activities | -171.3M +4,838.47% | -3.5M -97.82% | -159.2M -14.90% | -187.0M -0.98% | |
Capital Expenditures | 79,000 N/A | 0 N/A | 0 -100.00% | 410,000 -73.48% | |
Cash from Investing Activities | 156.4M +438.74% | 29.0M +126.15% | -111.0M +10,621.74% | -1.0M -99.12% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 6.4M +155.93% | -11.5M -106.04% | 190.2M +62.40% | 117.1M +3,417.27% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | -12.68% N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | -52.24% N/A | N/A N/A | N/A N/A | |
Return on Assets | -69.89% +287.73% | -18.03% -70.71% | -61.54% -17.35% | -74.46% +40.50% | |
Return on Equity | 365.33% +398.14% | -122.54% -74.50% | -480.50% +39.87% | -343.53% +224.55% | |
Revenue Growth | -100.00% N/A | N/A N/A | N/A N/A | N/A N/A | |
Current Ratio | 2.64 -61.61% | 6.88 +15.90% | 5.94 +11.67% | 5.32 -36.09% | |
Cash Ratio | 0.59 -41.89% | 1.02 +64.49% | 0.62 -72.64% | 2.27 -50.57% | |
Debt-to-Equity Ratio | -1.62 N/A | 0.00 -100.00% | 0.20 -89.87% | 1.95 N/A | |
Debt-to-Assets Ratio | 1.15 N/A | 0.00 -100.00% | 0.04 -54.04% | 0.09 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow